Keyphrases
Immune Response
100%
Percutaneous Intervention
100%
Immune Thrombocytopenia
100%
Heparin-induced Thrombocytopenia
100%
Heparin-induced
100%
Percutaneous Coronary Intervention
62%
Thrombin
37%
Bivalirudin
25%
Argatroban
25%
Lepirudin
25%
Steady State
12%
Treatment Modalities
12%
Heparin
12%
Anticoagulants
12%
Clinical Conditions
12%
Cross-reactivity
12%
Dosing Regimen
12%
Unfractionated Heparin
12%
Drug Choice
12%
Antithrombotic Agents
12%
Fluid Phase
12%
Hypercoagulable State
12%
Optimal Dosing
12%
Plaque Disruption
12%
Thrombosis Risk
12%
Fibrin Clot
12%
Direct Thrombin Inhibitors
12%
Periprocedural Anticoagulation
12%
Challenging Situation
12%
Medicine and Dentistry
Heparin
100%
Percutaneous Intervention
100%
Immunity
100%
Heparin-Induced Thrombocytopenia
100%
Thrombocytopenia
80%
Percutaneous Coronary Intervention
50%
Thrombin
30%
Bivalirudin
20%
Argatroban
20%
Lepirudin
20%
Anticoagulation
10%
Steady State
10%
Thrombosis
10%
Antithrombotic
10%
Anticoagulant
10%
Fibrin Clot
10%
Direct Thrombin Inhibitor
10%
Cross Reaction
10%
Nursing and Health Professions
Heparin
100%
Percutaneous Intervention
100%
Heparin Induced Thrombocytopenia
100%
Thrombocytopenia
80%
Percutaneous Coronary Intervention
50%
Thrombin
30%
Anticoagulant Agent
20%
Argatroban
20%
Bivalirudin
20%
Lepirudin
20%
Anticoagulation
10%
Thrombosis
10%
Thrombin Inhibitor
10%
Pharmacology, Toxicology and Pharmaceutical Science
Heparin
100%
Heparin Induced Thrombocytopenia
100%
Thrombocytopenia
80%
Thrombin
30%
Anticoagulant Agent
20%
Bivalirudin
20%
Argatroban
20%
Lepirudin
20%
Thrombosis
10%
Thrombin Inhibitor
10%
Immunology and Microbiology
Immunity
100%
Heparin Induced Thrombocytopenia
100%
Thrombin
44%
Liquid
11%
Steady State
11%
Cross-Reactivity
11%
Fibrin Clot
11%
Anticoagulation
11%
Immunology
11%
Neuroscience
Heparin
100%
Thrombin
25%
Bivalirudin
16%
Argatroban
16%
Lepirudin
16%
Antithrombotic
8%
Direct Thrombin Inhibitor
8%